Pfizer Animal Health to Acquire Synbiotics Corporation

Pfizer PFE Animal Health today announced an agreement to acquire Synbiotics Corporation (Pink Sheets: SYNB). Synbiotics estimates that its common shareholders will be entitled to receive up to approximately $0.306 per share in cash in connection with the acquisition, of which approximately $0.019 per share will be held in escrow as a fund against which Pfizer may make claims for losses arising from any breaches of Synbiotics' representations, warranties, covenants and agreements and similar customary matters. The acquisition is expected to close later this week.